CALLAN JMB INC.
CJMBNasdaq
$1.22
↑ +41.7%Jul 17 close · end-of-day
Price
1Y↓ -77.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.7M
Enterprise Value
$3.3M
P/E
—
P/S
0.9
P/B
2.9
EV/EBITDA
—
PEG
—
FCF Yield
-112.5%
Dividend Yield
—
Revenue (TTM)
$5.4M
Net Income (TTM)
-$9.9M
Free Cash Flow (TTM)
-$5.3M
Gross Margin
35.6%
Operating Margin
-139.4%
Net Margin
-184.8%
ROE
-621.5%
ROIC
-3219.6%
Debt / Equity
—
Net Cash
$1.4M
Return 1Y
-76.4%
Company profile
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We were originally formed as Coldchain Technology Services, LLC, a Texas limited liability company. We reorganized as a holding company to Callan JMB Inc., a Nevada corporation, on February 14 2024. We are headquartered at 244 Flightline Dr., Spring Branch, TX 78070.
- CEO
- Wayne Williams
- Sector
- Services
- Industry
- Business Services
- Employees
- 35
- Headquarters
- Texas
- Website
- callanjmb.com
Management & directors
- Croyle David JChief Medical Officer
- Williams Wayne DCEO, Chairman and President
Roles derived from SEC Form 4 filings.
Earnings
CJMB Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.1M↓ -23.7%
Diluted EPS-$0.32↓ -45.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $13.2M | $6.6M | $5.7M |
| Gross profit | $5.6M | $2.6M | $2.1M |
| Operating income | $2.2M | -$2.3M | -$7.0M |
| Net income | $2.2M | -$2.3M | -$8.0M |
| Diluted EPS | — | -$0.87 | -$1.82 |
| Operating cash flow | $7.0M | $540,353.00 | -$4.5M |
| Free cash flow | $6.5M | $494,186.00 | -$5.2M |
| Gross margin | 42.8% | 39.1% | 36.8% |
| Operating margin | 16.7% | -34.7% | -122.9% |
| Net margin | 16.5% | -34.9% | -139.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $1.4M | $1.4M | $1.4M | $1.7M | $1.4M | $1.2M | $1.1M |
| Gross profit | $962,216.00 | $464,445.00 | $419,019.00 | $615,940.00 | $643,870.00 | $493,307.00 | $351,424.00 | $427,235.00 |
| Operating income | -$133,423.00 | -$780,983.00 | -$1.3M | -$1.2M | -$1.4M | -$1.9M | -$2.5M | -$1.7M |
| Net income | -$112,476.00 | -$804,987.00 | -$1.3M | -$1.2M | -$1.4M | -$2.7M | -$2.6M | -$3.2M |
| Diluted EPS | -$0.04 | -$0.27 | -$0.53 | -$0.59 | -$0.31 | -$0.61 | -$0.31 | -$0.32 |
| Operating cash flow | $268,685.00 | $988,002.00 | -$723,173.00 | -$1.6M | -$563,272.00 | -$1.8M | -$658,987.00 | -$1.7M |
| Free cash flow | $267,467.00 | $987,709.00 | -$723,173.00 | -$1.6M | -$995,778.00 | -$1.9M | -$658,987.00 | -$1.7M |
| Gross margin | 48.5% | 32.4% | 31.0% | 42.5% | 38.6% | 34.1% | 30.3% | 38.6% |
| Operating margin | -6.7% | -54.4% | -94.2% | -85.4% | -84.2% | -129.9% | -216.6% | -153.8% |
| Net margin | -5.7% | -56.1% | -95.8% | -85.6% | -83.9% | -188.8% | -223.8% | -290.7% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-20 | Croyle David J· Chief Medical Officer | Buy | 10,195 | $1.75 | $17,841.25 | filing |
| 2026-03-06 | Croyle David J· Chief Medical Officer | Buy | 14,805 | $1.76 | $26,086.41 | filing |
| 2025-12-30 | Dial Gerald | Buy | 10,000 | $0.76 | $7,620.00 | filing |
| 2025-12-30 | Dial Gerald | Buy | 1,539 | $1.20 | $1,846.80 | filing |
| 2025-12-30 | Dial Gerald | Buy | 461 | $1.22 | $562.42 | filing |
| 2025-12-16 | Williams Wayne D· CEO, Chairman and President | Buy | 5,000 | $1.73 | $8,650.00 | filing |
| 2025-12-15 | Williams Wayne D· CEO, Chairman and President | Buy | 10,810 | $1.70 | $18,377.00 | filing |
| 2025-12-12 | Williams Wayne D· CEO, Chairman and President | Buy | 4,926 | $1.75 | $8,620.50 | filing |
| 2025-12-11 | Williams Wayne D· CEO, Chairman and President | Buy | 30,856 | $1.65 | $50,912.40 | filing |
| 2025-12-11 | Williams Wayne D· CEO, Chairman and President | Buy | 62 | $1.79 | $110.98 | filing |
| 2025-12-10 | Williams Wayne D· CEO, Chairman and President | Buy | 13,689 | $1.65 | $22,586.85 | filing |
| 2025-12-09 | Duke Liberty Smith | Buy | 612 | $1.52 | $930.24 | filing |
| 2025-12-08 | Duke Liberty Smith | Buy | 900 | $1.56 | $1,404.00 | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.